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Abstract
There is a lack of measures that reflect the intervention priorities of parents of children with autism spectrum disorder (ASD) 
and that assess the impact of interventions on family experience and quality of life. The Autism Family Experience Question-
naire (AFEQ) was developed through focus groups and online consultation with parents, and reflected parental priorities. 
It was then administered to the parents of children enrolled in the Pre-school Autism Communication Trial and its 6-year 
follow-up study. The AFEQ showed good convergent validity with well-established measures of child adaptive functioning, 
parental mental health and parental wellbeing. It was sensitive to change in response to a parent-mediated intervention for 
young children with autism, showing treatment effect at treatment endpoint which increased at six-year follow-up.
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Introduction
There is a notable paucity of parent-nominated measures 
designed to assess intervention outcomes for children with 
neuro-developmental disabilities, such as autism spectrum 
disorder (ASD), and their families (McConachie et al. 2015; 
Morris et al. 2014, 2015). Parents of children with ASD are 
often best placed to advocate for the interests and opinions 
of their children and to observe and report on their child’s 
progress, particularly when those children have significant 
intellectual and communicative disabilities and are unable 
to self-report (Morris et al. 2014). Many autism interven-
tions, particularly in the pre-school years, are parent-medi-
ated (e.g., Kasari et al. 2010; Oono et al. 2013; Pickles et al. 
2016; Rahman et al. 2016) and effective services for the 
child with ASD can have “spillover effects” for the rest of 
the family (Payakachat et al. 2012). Parents therefore have 
a vital contribution to make on two levels: (1) in specifying 
which intervention outcomes are important for their child, 
for themselves and for their family and thereby setting the 
success criteria for interventions, and (2) in reporting on the 
measures of those outcomes for their individual children.
The measurement of patient- and parent/carer-centred 
outcomes has become an integral part of the evaluation of 
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treatment effectiveness and cost-effectiveness in the UK and 
internationally (see, for example, the Promis System of the 
US National Institutes of Health 2017, and the NHS Out-
comes Framework of the UK Department of Health 2017). 
This gives the clear mandate that patients and their families/
carers should be central to the process of prioritising which 
outcomes matter most within any particular health domain 
and therefore determining the criteria by which interven-
tions are judged (Marshall et al. 2005; Morris et al. 2015; 
National Institute for Health and Care Excellence 2013; 
Tait and Lester 2005). This mandate extends to paediatric 
research, with an emphasis on the crucial role of parents 
and carers in nominating and reporting when their children 
are not developmentally able to do so themselves (Morris 
et al. 2009).
Alongside the policy drive for patient- and parent/carer- 
nominated outcomes, there has recently been increased 
attention more generally to the research priorities of indi-
viduals with ASD themselves and their parents and carers 
(Iemmi et al. 2017; McConachie et al. 2015; Pellicano et al. 
2014). Interventions to improve individual and family well-
being and quality of life are frequently cited as a priority by 
people with ASD and their parents and carers (McConachie 
et al. 2015; Pellicano et al. 2014). Despite this, the inclusion 
of patient- or parent-nominated measures or, indeed, any 
outcome measure of quality of life in autism intervention 
research, and particularly within randomised controlled tri-
als, is still uncommon (Burgess and Gutstein 2007; McCo-
nachie et al. 2015; Pellicano et al. 2014), with the emphasis 
firmly on child developmental outcomes such as intellectual 
ability, communication and language skills, play or autism 
symptomatology (e.g., Estes et al. 2015; Kasari et al. 2012; 
Kasari 2015; Pickles et al. 2016).
The measurement of quality of life in preschool children 
is complex (Eiser and Morse 2001; Grange et al. 2007). 
Standardised health-related quality of life indicators have 
been developed for childhood chronic conditions (Eiser and 
Morse 2001; Solans et al. 2008), such as the Pediatric Qual-
ity of Life Inventory (Varni et al. 2001), the EuroQol—5 
Dimensional Questionnaire—Youth (Wille et al. 2010) and 
the Child Health Utility—9 Dimensions (Stevens 2012). 
Such measures are psychometrically strong and effective in 
providing a metric of general wellbeing in children with a 
range of conditions, particularly physical illness. They have 
less utility for measuring condition-specific dimensions. 
They do not, for example, capture the unique and complex 
practical, social and emotional intricacies of living with 
ASD (Eapen et al. 2014). The World Health Organisation 
has identified this gap and is currently developing a com-
prehensive Core Set for Autism Spectrum Disorder (ASD) 
within its International Classification of Functioning, Dis-
ability and Health (ICF), which aims to describe the lived 
experience of individuals with ASD across various health, 
wellbeing and developmental domains (Bölte et al. 2014; de 
Schipper et al. 2016).
Whilst child-specific quality of life is an important out-
come within autism intervention work, a wider focus that 
encompasses the wellbeing of parents and the whole family 
system has been recommended, particularly within interven-
tion aimed at young children (Hastings et al. 2014; Payaka-
chat et al. 2012; Tint and Weiss 2016). The raised levels of 
fatigue, stress, anxiety and depression in parents of children 
with ASD are well documented (e.g., Dykens et al. 2014; 
Giallo et al. 2011; Quintero and McIntyre 2010). Siblings 
have also been shown to be at risk of higher levels of emo-
tional and behavioural difficulties (e.g., Rodrigue et al. 1993; 
Ross and Cuskelly 2006). These effects are, of course, often 
multi-directional: sibling wellbeing can be related to paren-
tal coping and stress (Tsai et al. 2016) and parental stress 
and distress can affect child adjustment and behaviour, as 
well as vice versa (Hastings et al. 2014; Totsika et al. 2013; 
Zaidman-Zait et al. 2014). However, importantly, parents 
of children with ASD emphasise that there are many posi-
tive aspects to their family life (McConachie et al. 2015) 
and several beneficial effects of having a sibling with ASD 
have been reported empirically, such as reduced conflict in 
the sibling relationship (Kaminsky and Dewey 2002) and 
increased general resilience (Bayat 2007). A strengths-based 
approach to ASD has also been called for by researchers 
(Burnham Riosa et al. 2017; McCrimmon and Montgomery 
2014). It would therefore be valuable to document family 
strengths, as well as difficulties.
Mental health constructs like parenting stress have been 
commonly utilised to tap parental wellbeing (e.g., Hayes and 
Watson 2013; Zaidman-Zait et al. 2014) and, more recently, 
quality of life indicators specific to parents of children with 
ASD have been developed, such as the Quality of Life in 
Autism Questionnaire (Eapen et al. 2014). However there 
is, to our knowledge, no parent-generated measure of family 
experience in the autism literature that can be used to assess 
the impact of an intervention. In this paper we describe 
the development of a parent-nominated measure of fam-
ily experience, quality of life and prioritised outcomes for 
early intervention designed to address this measurement gap. 
This measure was developed and tested within the context 
of a large randomised trial of a pre-school parent-mediated 
intervention.
Background: The PACT Intervention, Trial 
and Follow‑Up
Pre-school Autism Communication Therapy (PACT Ther-
apy) is a parent-mediated video-aided communication-
focussed intervention for pre-school children with autism 
and their parents. The UK Medical Research Council Pre-
school Autism Communication Trial (PACT Trial) was a two 
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arm parallel group randomised controlled trial (RCT) of 152 
pre-school children with core autism. It ran between 2006 
and 2009 across three UK centres (Manchester, London and 
Newcastle) and evaluated the effectiveness of PACT therapy 
plus treatment-as-usual (TAU) versus TAU alone (Green 
et al. 2010; Pickles et al. 2015). A subsequent follow-up 
phase assessed outcomes at 6 years after the end of the treat-
ment phase (Pickles et al. 2016). The trial was registered on 
International Standard Randomised Controlled Trial, num-
ber ISRCTN58133827, and the protocol is available at http://
research.bmh.manchester.ac.uk/pact.
At trial entry, all children had a clinical diagnosis of 
autism and met criteria for core autism on the researcher-
administered Autism Diagnostic Observation Schedule - 
Generic (Lord et al. 2000) and two of the three domains 
of the Autism Diagnostic Interview—Revised (Lord et al. 
1994). 77% of the sample was not yet using regular, sponta-
neous phrase speech. The sample was ethnically and socio-
economically diverse (57% white; 23% single parents; 74% 
with at least one parent with post-16 qualifications). The 
PACT treatment group consisted of 77 children (6 girls) 
aged 26–60 months (mean age = 45 months) with a mean 
non-verbal IQ age equivalence of 27 months. The TAU con-
sisted of 75 children (8 girls) aged 24–60 months (mean 
age = 45 months) with a mean non-verbal IQ age equiva-
lence of 25 months. Other demographic details of families 
were balanced across the arms at baseline. The trial showed 
a strong treatment effect in favour of the PACT intervention 
in observed parental synchronous responsive behaviours and 
child communicative behaviours in dyadic communication, 
and in parent-reported outcome ratings on child language 
and social communication. However, there were more mod-
est effects on child social affective autism symptoms and on 
standardised objective tests of child language (Green et al. 
2010). At follow up 80% of the sample was assessed (mean 
age 10.5 years; SD = 0.8; n = 121). Intention-to-treat analy-
sis based on initial randomisation showed a reduction of 
autism symptom severity at treatment endpoint which was 
sustained to 6-year follow-up and represented a 17% relative 
reduction in symptom severity in the treatment arm (Pickles 
et al. 2016). The improvement in child dyadic communica-
tive behaviours seen in the intervention group at trial end-
point was sustained into follow-up, but standardised meas-
ures of language development continued not to show group 
differences.
The commissioning and protocol of the PACT trial 
included a strategy to promote involvement of service users 
in pre-trial research design, and to address the measure-
ment gap in relation to family experience outcome meas-
ures through the development of a parent-generated meas-
ure of child and family wellbeing for use in the trial. This 
new measure aimed to reflect both parental report of their 
personal and family experience, and their autistic child’s 
development and adjustment. The specific focus was on 
whether the parental priorities for change were achieved 
through the pre-school intervention. It was hypothesised 
that, as the PACT intervention works partly through chang-
ing the quality of parental responsiveness to child commu-
nication, it could result in more general positive changes in 
family life, and improved parental confidence and morale. 
Since the assessment had not been developed prior to the 
trial, data from the resulting instrument would not be used in 
the formal outcome analysis, but secondary post hoc analy-
ses could contribute to the evaluation of this prototype of 
an autism specific, parent-nominated change measure that 
could be suitable for future intervention and other research.
Methods
Developing the Measure
A two-phase process was used. Firstly, a series of focus 
groups was held with parents of children with autism to gen-
erate a core set of outcome parameters. Secondly, we imple-
mented a larger web-based consultation using the resources 
of the UK National Autistic Society (www.autism.org.uk) in 
order to subject the initial parameters to wider review, com-
ment and refinement. Such a method is an extension of rec-
ommended methods for developing measures of this kind 
(e.g., Eiser and Morse 2001, p. 90).
Focus Group Phase
Thirty-one parents of pre-school or school-aged children 
with autism were recruited from local clinical services and 
parent-support groups and attended one of five focus groups 
(four held in Manchester UK and one in Newcastle UK; 
4–11 participants in each group). The groups were convened 
and led by members of the PACT Principal Investigator team 
and an independent qualitative researcher (WM). The aims 
of the focus groups were to explore the specific parameters 
that parents identified as the most important outcomes from 
a pre-school communication intervention for autism. Fol-
lowing consultation with parents and stakeholders at the 
National Autistic Society, four key topics of enquiry were 
pre-specified: (a) parental personal life and relationships; 
(b) general family functioning (including sibling needs); (c) 
specific outcomes for the child with autism related to general 
development, communication and learning; (d) the child’s 
symptoms in terms of emotional wellbeing and behaviour. 
The initial orientating question for the groups was: ‘Given a 
communication-focused intervention for a child with autism 
in the preschool years, what would be the key aspects of 
family life, child behavior or development that—if they 
changed—would make you feel the intervention had been a 
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success?’ Focus group leaders structured the groups to cover 
the pre-specified domains without directing the content.
Qualitative Analysis
Audio-tapes of each focus group meeting were transcribed 
for analysis using NUDIST software in a constant compara-
tive method (Glaser and Strauss 1967). An initial thematic 
coding framework was devised and the transcripts analysed 
line-by-line and coded against the framework. Themes 
obtained were then discussed with the wider team and con-
stant comparison was used to refine a final set of themes. 
Individual statements were then abstracted from these 
themes to serve as response items within the questionnaire. 
This process resulted in 78 questionnaire items. Examples of 
the themes and the abstracted questionnaire items are shown 
in Table 1.
Website Consultation
The 78 items derived from these focus group themes 
were uploaded in the form of a draft questionnaire onto 
an online survey facility within the website of the UK 
National Autistic Society. This website facility allowed the 
presentation of the items of the draft questionnaire, con-
textualised with an introduction about its aims. Respond-
ents rated each question against two criteria: (1) Clarity: 
comprehensibility and lack of ambiguity; (2) Usefulness 
of the question for evaluating the effectiveness of a com-
munication treatment for autism. The website consultation 
was live over a 10-day period in February/March 2006. 
Over this period, 35 completed questionnaire responses by 
parents of children with autism were received and collated 
by staff at the National Autistic Society.
Table 1  Examples of focus group themes and resulting questionnaire items
Domain Theme Questionnaire item
Parent Parental battle: High levels of frustration from having to con-
stantly ‘fight’ for support for their child
“It’s a continual battle to get the right help for my child”
Realistic expectations: For many parents having realistic expec-
tations about the rate of improvement they could expect from 
an intervention was important. There was general understand-
ing that they needed to adjust to a new set of milestones for 
their child with autism. For some parents the slow rate of 
change was very difficult to come to terms with, whilst for 
other parents (particularly of older children) there was an 
appreciation of the slower rate of change and improvement 
they had observed in their child, often over years
“I have realistic milestones for my child’s development”
Family Wider family attitudes: Some parents talked about the lack of 
acceptance and understanding of their child in the wider fam-
ily and this lack of understanding making it difficult for them 
to attend extended family events and occasions
“I feel confident to go out to family events with my child”
Routines and structure at home: There was discussion around 
the problems around transition between school and home and 
the problems because of a perceived lack of structure and 
‘routine’ in the home environment
“I feel confident in making routines at home more man-
ageable for my child”
Child development Changes in child’s social experience: All parents wanted their 
child to be able to play with other children, to develop and 
keep friendships, and to be socially accepted and included. 
One key consensus marker of improved social experiences and 
relationships mentioned by several parents was if their child 
was invited to birthday parties
“My child gets invited to birthday parties”
Ability to communicate illness A number of parents described 
the difficulty associated with their child’s inability to under-
stand physical symptoms, what is going on in their body and 
to communicate physical symptoms to others
“I know when my child feels poorly”
Child symptoms Emotional development: Parents were looking for strategies that 
could help their child to understand and express their feelings 
and as a parent to understand their child’s feelings in order to 
help them to be happier and more relaxed
“My child is happy”
Family outings: A recurring theme was the desire to be able to 
go out as a family without being overwhelmed by feelings of 
embarrassment
“My child is embarrassing when going out”
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Analysis of Ratings
The web consultation resulted in weighted ranks against 
both criteria (i.e., clarity and usefulness) for each of the 
items presented. Items rated in the bottom quintile for rel-
evance were discarded. Items weighted highly for relevance 
but low for clarity were retained but re-worded, or discarded 
if it was difficult to rephrase the item into a short and simple 
statement that was clearer.
Data Preparation Within the PACT Trial 
and Follow‑up
The resulting questionnaire had 56 items. Items included 
both positively and negatively worded statements and were 
scored on an order scale: 1 = always to 5 = never, with an 
option for “Not Applicable”. Items were organised into 
domains which matched onto the pre-specified focus-group 
topics: (1) experience of being a parent of a child with 
autism; (2) family life, (3) child development (development, 
understanding and social relationships); and (4) child symp-
toms (feelings and behaviour). This questionnaire was then 
rated by parents, with researcher support if requested, as 
part of the baseline and endpoint assessments of the PACT 
trial. Prior to group unblinding and analysis, this data was 
then subject to initial data cleaning. Eight items that were 
rarely endorsed were excluded, including items on language 
(when many children were non-verbal), and siblings (when 
there often were none). The resulting 48 item questionnaire 
was named the Autism Family Experience Questionnaire 
(AFEQ; Online Appendix I). Items were organised into the 
four pre-specified domains; Table 2 shows how items map 
onto these domains. The AFEQ included both positively 
and negatively worded statements and was scored on an 
order scale: 1 = always to 5 = never, with an option for “Not 
Applicable”. The 48-item AFEQ was then used in the PACT 
6-year follow-up study.
Data Analysis
We planned an initial descriptive analysis of the pattern of 
AFEQ scores across the three time-points and an exami-
nation of the internal consistency of the domain scores 
and total score. A pre-specified analysis plan of the AFEQ 
data (included in the original trial proposal and protocol) 
included a study against an external criterion referent for the 
child development domain of the AFEQ, using the parental 
Vineland Adaptive Behavior Scales, Second Edition (VABS; 
Sparrow et al. 2006), a well-validated parent-rated scale 
of child adaptive functioning. An additional analysis was 
planned within the follow-up phase of the trial to assess the 
convergent validity of the parent domain of the AFEQ with 
a study of the association of the parent domain with a well-
established measures of adult mental health—the General 
Health Questionnaire-12 Items (GHQ-12; Goldberg 1992)—
and of adult wellbeing—the Warwick-Edinburgh Mental 
Wellbeing Scale (WEMWBS; Tennant et al. 2007).
The initial pre-specified analysis plan included the exami-
nation of the change in AFEQ over time between treatment 
and TAU groups. For this treatment effect estimate we pos-
tulated a priori hypotheses based on the nature of the inter-
vention and potential effects on aspects of family experience 
contained within the AFEQ. Thus we predicted that, com-
pared to TAU, the PACT intervention would result in relative 
improvements at trial endpoint and at 6-year follow-up in: 
(1) the total AFEQ score; (2) each of the four domain scores 
(parent, family life, child development and child symptoms).
We compared baseline, endpoint and follow-up AFEQ 
total and domain scores between groups using an intention-
to-treat approach, using the same analytic model as in the 
main analysis (Green et al. 2010; Pickles et al. 2016): each 
outcome was analysed separately using linear regression 
(analysis of covariance) including baseline measures of 
the outcome as covariate. In line with the main analyses 
we adjusted for the same set of baseline covariates as fixed 
effects, namely: age group (≤ 42 months, > 42 months), sex, 
centre (Manchester, London, Newcastle), non-verbal abil-
ity (mean non-verbal age-equivalent on the Mullen Scales 
of Early Learning; Mullen 1995), socioeconomic status 
(dichotomised as at least one parent with post-16 qualifica-
tions versus all others) and parental education (dichotomised 
as at least one parent in professional or administrative occu-
pation versus all others). These were variables pre-specified 
as potentially having an effect on outcome scores independ-
ent of treatment.
Results
Descriptive Analysis of AFEQ and Internal 
Consistency
Of the total sample of 152 participants, AFEQ data were 
obtained from 145 parents at baseline assessment (7 par-
ticipants had completely missing data), from 140/145 (97%) 
parents at trial endpoint (13 months later; 12 completely 
Table 2  Autism family experience questionnaire domains and items
Domain Items
Experience of being a parent 1–13
Family life 14–22
Child development, understanding and social relationships 23–36
Child symptoms (Feelings and behaviour) 37–48
Total AFEQ Score 1–48
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missing data), and from 105/145 (72%) parents at follow-
up, 6 years from end of treatment. There were no significant 
demographic differences between the baseline sample and 
those for whom we had follow-up data. Total AFEQ scores 
were derived from these data. Individual items that were 
missing or entered as NA were pro-rated with mean scores 
of all items. Items that were negatively worded were reverse 
scored, so that throughout the data a lower score indicates 
a positive outcome, and a higher score is a poor outcome 
(minimum possible score is 48, maximum possible is 240).
At baseline, the total score for the sample as a whole had 
mean 141.0 (SD = 21.3), median 141.0 (range 81.8–188.0). 
At endpoint, the whole sample total score had mean 133.0 
(SD = 22.8), median 134.4 (range 64.0–180.0). At follow-up, 
the total score had a mean 132.5 (SD = 24.6), median 133 
(range 78.1–196.2). Therefore there was a slight reduction in 
scores between baseline and endpoint and stability on scores 
between endpoint and follow-up.
In order to assess the internal consistency of the 48 item 
questionnaire, we examined the scale reliability based on 
Cronbach’s alpha for the domain scores and the AFEQ total 
score, calculated from baseline data. All domains and the 
total score demonstrated excellent reliability at baseline: par-
ent (alpha = 0.85), family (0.83), child development (0.81), 
child symptoms (0.79), AFEQ total (0.92).
Comparative Analysis Against Parental VABS
For comparison and to assess the external criterion valid-
ity of the AFEQ, we correlated the scores on the AFEQ 
child development domain (items 23–36; 14 items) with 
the VABS total score at baseline, endpoint and follow-up. 
Both AFEQ and VABS were completed with 143 families 
at baseline (2 missing VABS in addition to the 7 missing 
AFEQs); 134 at endpoint (6 missing VABS in addition 
to the 12 missing AFEQs); and 102 at follow-up (3 miss-
ing VABS in addition to the 47 missing AFEQs). Recall-
ing that a positive outcome is indicated by a low score 
on the AFEQ and a high score on the VABS, we would 
anticipate a significant negative correlation to indicate that 
the scales were producing similar results. The correlation 
between the VABS and child developmental AFEQ subto-
tal at baseline was r = − 0.478 (p < .001, n = 143), at end-
point was r = − 0.575 (p < .001, n = 134), and at follow-up 
was r = − 0.710 (p < .001, n = 102), indicating a moderate to 
strong association between the two measures at each of the 
three time-points.
Comparative Analysis Against Parental Mental 
Health and Wellbeing Measures
To assess the external criterion validity of the parent domain 
of the AFEQ, we tested for an association between the parent 
domain score (items 1–13) and the GHQ-12 and WEMWBS 
total scores at trial follow-up. These adult mental health and 
wellbeing scales were not used as part of the trial baseline 
or endpoint assessment battery, so these analyses could not 
be conducted. The GHQ-12 total score was computed using 
the ‘GHQ scoring method’ (items scored 0-0-1-1; Goldberg 
1992), with missing items recoded as low scores, resulting 
in a total score between 0 and 12, where a higher score indi-
cates poorer mental health. Both the AFEQ and the GHQ-12 
were completed by 101 parents (4 missing GHQ-12 ques-
tionnaires in addition to the 47 missing AFEQs). The cor-
relation between the parent domain score and GHQ-12 was 
Spearman’s Rho = 0.408 (p < .001, n = 101; a Spearman’s 
rank correlation was conducted as the GHQ-12 distribu-
tion was highly positively skewed). The WEMWBS total 
score was the sum of scores on all 14 questionnaire items, 
with missing data on individual items pro-rated, resulting 
in a total score ranging from 14 to 70 where a higher score 
indicates increased wellbeing (Tennant et al. 2007). Both 
the WEMWBS and the AFEQ were completed by 103 par-
ents (2 missing WEMWBS questionnaires on top of the 47 
missing AFEQs). The correlation between the AFEQ parent 
domain score and the WEMWBS total score was r = − 0.528 
(p < .001, n = 103).
Treatment Effect Estimation
The results of the treatment effect estimation analysis (mean 
differences and effect sizes [Cohen’s d]), along with sum-
mary statistics of the total and domain scores, are shown in 
Tables 3 and 4.
On the 48 item AFEQ total score, there was a statistically 
significant improvement of PACT over TAU at both trial 
endpoint and at 6-year follow-up, with a stronger effect at 
follow-up than at endpoint (Cohen’s d = − 0.49 and − 0.29, 
respectively). The treatment effects on the family domain 
score were non-significant at both endpoint and follow-up. 
On the parent domain there was a significant and moderately 
strong treatment effect at follow-up (d = − 0.53), which was 
not seen at trial endpoint. On the child development domain 
we found a significant effect of the treatment at endpoint (d 
= − 0.28), which was not sustained six years later and on 
the child symptoms domain we found a marginal effect at 
endpoint (d = − 0.31), also not sustained at follow-up.
Discussion
The aim of the study was to develop a parent-generated 
measure of family outcomes in the context of a RCT of 
a parent-mediated video-aided pre-school communica-
tion-focused intervention for young children with autism 
(the PACT trial). In keeping with the patient- and parent/
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carer-centred outcome agenda and the research priorities 
of people with ASD and their families (Iemmi et al. 2017; 
McConachie et al. 2015; Pellicano et al. 2014), the AFEQ 
is truly user-generated. Our procedure started prior to the 
trial itself with focus groups and an online consultation with 
parents of children with ASD to generate parents’ own for-
mulations of the priorities for early intervention outcomes. 
Participating parents were asked to consider the key out-
comes under four domains: for themselves as parents, for 
their family as a whole, for their child’s development, and 
for their child feelings and behaviour (child symptoms). The-
matic analysis generated themes which were formed into 
statements to serve as questionnaire items. The final selec-
tion of items was made using parental ratings of clarity and 
usefulness collected in the online consultation.
We conclude that such a process is feasible and produc-
tive and has culminated in a viable, ecologically-valid instru-
ment with good internal consistency. Parents within the trial 
reported that they found the measure easy to complete and 
that they valued the opportunity to report real-life experi-
ences for their children and other family members on metrics 
nominated by other parents of a child with ASD. These anec-
dotal reports are consistent with the findings that individuals 
with ASD and their parents and carers value wellbeing and 
quality of life as outcomes measures within intervention 
research (McConachie et al. 2015; Pellicano et al. 2014).
The importance of considering external validity in trials 
has been highlighted in the field of autism (Jonsson et al. 
2016) and includes the extent to which new skills carry over 
into everyday life and valued outcomes. As an initial test of 
external validity we undertook a planned a priori analysis 
of the relation to the parent rated Vineland Adaptive Behav-
ior Scales (VABS; Sparrow et al. 2006). This widely-used 
measure relates to child adaptive behaviour in a number of 
domains and thus was an obvious comparator for the AFEQ 
child development domain. There was a high correlation 
between the AFEQ and the VABS at each of the three time-
points of the PACT trial, in keeping with our hypothesis in 
the trial protocol that the parental VABS would act as an 
initial external validation of the child development domain 
of the newly developed instrument. A further test of the 
convergent validity of the AFEQ was the analysis of the 
association of the AFEQ parent domain and well-established 
measures of adult mental health - the General Health Ques-
tionnaire (GHQ-12; Goldberg 1992)—and wellbeing—the 
Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS; 
Table 3  Summary statistics on AFEQ total and subscale scores for the PACT treatment and treatment-as-usual groups at baseline, endpoint and 
6-year follow-up
AFEQ low score = more positive outcome
AFEQ Domain
Mean (SD)
PACT intervention group Treatment-as-usual group
Baseline n = 76 Endpoint n = 72 Follow-up n = 51 Baseline n = 69 Endpoint n = 68 Follow-up n = 54
Total score 140.92 (21.78) 130.36 (23.59) 128.80 (28.11) 141.04 (21.00) 135.76 (21.66) 136.00 (20.52)
Parent 35.58 (7.62) 30.81 (7.28) 31.81 (7.72) 33.77 (6.76) 30.96 (7.08) 33.31 (7.91)
Family 26.07 (6.08) 25.18 (6.57) 23.37 (7.09) 25.65 (6.12) 25.54 (6.53) 25.02 (6.00)
Child development 44.68 (8.15) 41.27 (7.75) 39.72 (10.79) 46.43 (7.58) 44.44 (8.53) 42.37 (8.01)
Child symptoms 34.59 (5.82) 33.10 (6.29) 33.89 (5.49) 35.19 (5.71) 34.83 (5.84) 35.30 (4.93)
Table 4  Treatment effect estimates
Negative coefficient = more beneficial effect for PACT compared to TAU
AFEQ domain Endpoint Follow-up
Mean difference (SE), p 
value
95% CI Effect size
95% CI
Mean difference (SE), p 
value
95% CI Effect size
95% CI
Total score − 6.22 (3.12), 0.048 − 12.39, − 0.06 − 0.29
− 0.58, − 0.00
− 10.44 (4.90), 0.036 − 20.18, − 0.71 − 0.49
− 0.95, − 0.03
Parent − 1.44 (1.08), 0.185 − 3.57, 0.07 − 0.20
− 0.49, 0.01
− 3.87 (1.64), 0.021 − 7.14, − 0.60 − 0.53
− 0.98, − 0.08
Family − 0.88 (0.92), 0.342 − 2.69, 0.94 − 0.14
− 0.43, 0.15
− 2.42 (1.34), 0.075 − 5.09, 0.25 − 0.38
− 0.81, 0.04
Child development − 2.20 (1.10), 0.048 − 4.38, − 0.02 − 0.28
− 0.55, − 0.00
− 3.02 (1.78), 0.094 − 6.56, 0.52 − 0.38
− 0.83, 0.07
Child symptoms − 1.80 (0.91), 0.050 − 3.60, 0.00 − 0.31
− 0.63, 0.00
− 1.36 (1.07), 0.207 − 3.48, 0.76 − 0.24
− 0.60, 0.13
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Tennant et al. 2007), collected during the follow-up phase. 
A significant correlation with these measures suggested that 
the newly developed domain was tapping a construct that is 
linked to parental mental health and wellbeing.
An interesting point of note from the descriptive analysis 
was that the AFEQ total score taken across the two groups 
showed a slight reduction (improvement) between baseline 
and endpoint and then remained fairly stable to follow-up. 
The pattern of domain scores across timepoints shown in 
Table 3 suggests that this pattern is driven mainly by: (1) 
reductions in the parent and family domain scores in the 
PACT group only, and (2) decreases in scores in the child 
development domain across both groups, the latter perhaps 
reflecting developmental change across childhood.
A planned analysis within the trial protocol was to test the 
estimation of treatment effect based on the AFEQ. We found 
that the AFEQ total score showed a significant treatment 
effect at the 13-month trial endpoint and at 6-year follow-
up, with a larger effect size at follow-up than at endpoint. 
These findings provide evidence that the AFEQ total score 
is sensitive to change in the expected direction in response 
to a parent-mediated intervention for young children with 
autism. They suggest that the AFEQ is tapping short and 
longer term benefits from the PACT intervention that extend 
beyond, and complement, the standardised observational and 
parent-report measures of child development and function-
ing reported in our main papers (Green et al. 2010; Pickles 
et al. 2016). A treatment effect was also seen on the child 
development domain at endpoint, consistent with the other 
positive parental report of outcomes on child social com-
munication and language development at endpoint reported 
in our main paper (Green et al. 2010).
At follow-up, the parent domain showed a significant and 
moderately strong treatment effect; the family, child develop-
ment and child symptoms domains showed non-significant 
changes over this time period. The six-year improvement 
in the parent domain seen in the treatment group is particu-
larly illuminating, as this domain does not directly address 
aspects of the child’s functioning and wellbeing, but instead 
aspects of the parent’s coping, confidence and self-efficacy. 
We interpret this as showing that early parent-mediated 
intervention of this kind with relatively low intensity can 
bring about such sustained reported benefits on parental 
experience and morale years later. This adds weight to the 
notion that effective early intervention may lead to spillo-
ver effects for the wider family (Payakachat et al. 2012). It 
is also intriguing that the AFEQ parent domain showed a 
treatment effect given that the PACT therapy did not have 
a protective effect on parental mental health and wellbeing, 
over and above other child and family risk factors, when 
measured with established instruments (GHQ-12 and WEM-
WBS) and given that the AFEQ is well-correlated with these 
measures. As intended by its method of development, it may 
well be that the AFEQ items taps constructs that are more 
directly and specifically influenced by a parent-mediated 
intervention (e.g., items such as “I feel listened to by profes-
sionals” and “I feel I know how to help my child progress”), 
compared to the more general mental health and wellbeing 
constructs assessed by the GHQ-12 and the WEMWBS. The 
AFEQ may therefore be more sensitive to change result-
ing from an autism intervention, compared to more general 
questionnaires.
To balance its ecological validity as a parent-nominated 
measure, the AFEQ is completed unblind to treatment allo-
cation (as is inevitably the case in psychosocial trials of this 
kind) and thus is subject to expectation effects that can sub-
stantially inflate estimates of treatment effect, compared to 
trials which use blind-rated outcomes (Sonuga Barke et al. 
2013). The strength of the correlations between AFEQ and 
other questionnaire measures (GHQ-12 and WEMWBS) 
may be subject to common rater biasing, as they were often 
completed at the same session; the VABS, on the other hand, 
was completed as an interview and often in a different ses-
sion, and this correlation may be less subject to bias. These 
biases must be borne in mind in the interpretation of the 
results, but are an intrinsic part of self-reports of lived expe-
rience and it is precisely this subjectivity that is valuable in 
this context, particularly when it is able to complement more 
objective blind-rated measures.
The AFEQ was designed to measure parental priorities 
for key outcomes of an early intervention for their autistic 
child and family. An interesting question is whether the final 
questionnaire measures what we, as its developers, hoped 
it would. As researchers, we are confident that the items 
do indeed reflect parental priorities: all the questionnaire 
items were generated directly from discussions by parents in 
response to open questions designed to tap these priorities. 
However, there are two issues which we feel were under-
represented within the questionnaire: the issue of sibling 
relationships and that of parental couple relationships. A 
number of themes related to siblings were raised within the 
focus groups. One item specifically about siblings had to 
be removed in the data preparation phase as it generated 
large amounts of missing data in families with only one 
child. Other items (e.g., “I feel guilty about not giving other 
members of the family enough attention”) were phrased in 
such a way that they could be interpreted as being about 
siblings in families who had more than one child, but did not 
ask specifically about sibling relationships. Future research 
might seek to develop a “sibling relationship” questionnaire 
which could be used alongside the AFEQ by families with 
more than one child. Another issue that may be under-rep-
resented within the questionnaire is that of parental couple 
relationships and how these are affected, both positively and 
negatively, by having a child with autism within the family. 
Parents in the focus groups did not provide any discussion 
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around this issue, perhaps due to inhibitions around discuss-
ing this personal topic in a group of relative strangers. This 
is something that could also be addressed in future research; 
possibly one-to-one interviews with parents or written ques-
tionnaires would be more likely to elicit reflection on this 
topic.
In summary, the AFEQ holds promise as a viable, par-
ent-nominated measure of family life, prioritised interven-
tion outcomes and change indicators. It was developed in 
a sequential manner to be truly user-generated, shows eco-
logical validity and is sensitive to change. It is not in itself 
intended as a formal Quality of Life Measure but might be 
used in future work alongside generic quality of life meas-
ures, to evaluate family experience and to test associations 
between family experience and other factors, such as demo-
graphic variables and parental mental health. It could be 
applied in a number of research, health care and develop-
mental settings to quantify the experience of families of chil-
dren with autism and similar neurodevelopmental disorders.
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